Boardman LA

ORCID: 0000-0002-1330-2054 · 1 paper in corpus · active 2023
2023
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma.
Clinical cancer research : an official journal of the American Association for Cancer Research ·doi:10.1158/1078-0432.ccr-22-3168

PurposeTo assess whether MUC1 peptide vaccine produces an immune response and prevents subsequent colon adenoma formation.Patients and methodsMulticenter, double-blind, placebo-controlled randomized trial in individuals age 40 to 70 with di…